DFCI — Boston, Massachusetts

DFCI is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

DFCI has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Cancer, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML).

Sponsors: Dana-Farber Cancer Institute, Solu Therapeutics, Inc, Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DFCI?

DFCI has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DFCI conducted?

DFCI has 6 clinical trials on record, with 2 currently active. Their work covers Cancer, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML).

Is DFCI accredited by Crixeo Health?

Yes — DFCI holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about DFCI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.